2014 ovarian cancer national conference: prevention and alternative therapies

2

Click here to load reader

Upload: ovarian-cancer-national-alliance

Post on 17-Aug-2015

23 views

Category:

Health & Medicine


9 download

TRANSCRIPT

Page 1: 2014 Ovarian Cancer National Conference: Prevention and Alternative Therapies

Ovarian Cancer Prevention and Alternative Therapies

Potential Causes

Error in DNA Replication Cycle-Primary Cause is Inflammation

Deglycosylation of Gc protein by Nagalase (a protein that inhibits Gc protein from converting into MAF)

from tumor cells

Intracellular Bacteria

Increased Viral Load

Cavitations in the Jaw/Teeth (Root canals)

Increased IgG immune Response

Follow up Testing

AMAS test (Anti-Malignin Antibody in Serum)

Nagalase Testing in Blood: Health Diagnostics and Research Institute

CA-125 levels (Labcorp, Quest)

Alternative Therapies and Prevention

GcMAF

High Dose Vitamin C IV infusions

Diet and Lifestyle Modification (Overhaul)- eliminate sugar, dairy, wheat, etc/ saute foods with proper

oils, reduce stress

Anti-inflammatory Protocols (curcumin, allergy elimination, virus and bacteria eradication, etc)

Carcinosin, Arsenicum homeopathics, Cavitation Removal

Vitamin D supplementation

Treatment of Heavy Metals and Pesticide/chemical exposure

UVBI with ozone (produces aerobic conditions)

IV administration Hydrogen Peroxide

Colonic hydrotherapy, constitutional hydrotherapy

Herbs: Podophyllum peltanum, cat’s claw, chaparral, curcumin, dang shen, blood root, astragalus,

oregano, burdock, sheep sorrel

IV Mistletoe (viscum album), BX antitoxin (Delta Institute of Panama)- Maesa perlarius, Striga asiatica,

Scrophulariaceae, Drosera rotundifolia

Page 2: 2014 Ovarian Cancer National Conference: Prevention and Alternative Therapies

References

Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med. 2001 May-Jun;7(3):57-66, 68-72, 74-6.

Hancock VK, Knott EK. “Irradiated blood transfusion in treatment of infections,” Northwest

Medicine 1934; 33: 200

Korbelik M, VR Naraparaju, N Yamamoto. The value of serum alpha-N-acetylgalactosaminidase

measurement for the assessment of tumour response to radio- and photodynamic therapy. Br

J Cancer, 77:1009-1014, 1998.

Pacini S, Punzi T, Morucci G, Gulisano M, Ruggiero M. Effects of Vitamin D-binding Protein-

derived Macrophage-activating Factor on Human Breast Cancer Cells. Anticancer Res. 2012

Jan;32(1):45-52.

Uto Y, Yamamoto S, Takeuchi R, Nakagawa Y, Hirota K, Terada H, Onizuka S, Nakata E, Hori H.

Effect of the Gc-derived macrophage-activating factor precursor (preGcMAF) on phagocytic

activation of mouse peritoneal macrophages. Anticancer Res. 2011 Jul;31(7):2489-92.

Yamamoto N, Naraparaju VR. 1998. Structurally well-defined macrophage activating factor

derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.

Immunol Cell Biol 76:237–244.

Yamamoto, N., Naraparaju, V. R., and Asbell, S. 0. Deglycosylation of serum vitamin D3-binding

protein leads to immunosuppression in cancer patients. Cancer Res.56:2827-2831,1996.